Description: Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products in the People's Republic of China. Its Pharmaceutical Distribution segment offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. This segment distributes medicines, medical devices, and pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. The company's Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2017, this segment had 3,834 retail pharmacies, including 2,801 directly operated by the company and 1,033 operated by franchisees. Its Other Business segment engages in the distribution of medical devices; provision of financial leasing services; and production, sale, and distribution of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Home Page: www.sinopharmgroup.com.cn
Sinopharm Group Building
Shanghai,
200023
China
Phone:
86 21 2305 2666
Officers
| Name | Title |
|---|---|
| Mr. Qingming Yu | Exec. Chairman |
| Mr. Yong Liu | Pres & Exec. Director |
| Mr. Xiuchang Jiang | CFO & VP |
| Ms. Xiaojuan Li | Chief Financial Officer |
| Mr. Yijian Wu | Sec. to the Board, Company Sec. & Authorised Representative |
| Mr. Wanyong Lian | VP |
| Mr. Shuangjun Xu | Non-Exec. VP |
| Mr. Maisong Cai | VP |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 6.8259 |
|---|---|
| Trailing PE: | 7.1081 |
| Price-to-Book MRQ: | 0.8835 |
| Price-to-Sales TTM: | 0.0144 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 113234 |